Oxatomide

CAS: 60607-34-3

Ref. TM-T19839

Produktinformation

• Name: Oxatomide
• Synonyme: Oxatomida, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone, 1-[3-(4-Benzhydrylpiperazin-1-ium-1-yl)propyl]benzimidazol-2-olate, 1-[3-[4-(Diphenylmethyl)piperazin-1-ium-1-yl]propyl]-1H-benzimidazol-2-olate, 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-1,3-dihydro-2H-benzimidazol-2-one, 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-, 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-, Brn 4724760, Celtect, Cobiona, Dasten, Kw-4354, McN-JR 35443, NSC 309710, Oxatimide, Oxatomida [INN-Spanish], Oxatomide [USAN:INN:BAN:JAN], Oxatomidum, Oxatomidum [INN-Latin], Oxetal, R 35443, Tinset, Unii-J31Il9Z2Ee
• CAS: 60607-34-3

Beschreibung

Oxatomide (Oxatomida) is a potent and orally active dual H1 histamine receptor and P2X7 receptor antagonist with antihistamine and antiallergic activity.Oxatomide can be used to block ATP-induced currents in the human P2X7 receptor with an IC50 value of 0.95 μM.Oxatomide has an inhibitory effect on ATP-induced Ca2+ inward currents with an IC50 value of 0.43 μM.Oxatomide inhibits 5-hydroxytryptamine. Oxatomide inhibits 5-hydroxytryptamine with an IC50 of 0.43 μM.Oxatomide is used in the treatment of immune system diseases and in the study of hypersensitivity reactions.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 426.55
• Formel: C₂₇H₃₀N₄O
• Reinheit: 98.93%
• Farbe/Form: White Powder